Menu

GSK Exempts Oklahoma from 340B Contract Pharmacy Restrictions

Shannon Young, Associate Editor/Senior Writer 340B Report Views
GSK is exempting Oklahoma covered entities from its 340B contract pharmacy restrictions.
Oklahoma covered entities will soon be exempt from GSK’s 340B contract pharmacy restrictions thanks to a new contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Expert Tip from Avita Care Solutions

CBO Estimates Reconciliation Act’s Orphan Drug Medicare Negotiation Exemption Could Cost $8.8 Billion

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live

Sliding Sidebar

Link to spotlight on Sean Hall of Visante

340B Report Categories

More Categories

Recent Articles

Article Archives